Every Form 4 that AvePoint, Inc. (AVPT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AVPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AVPT filings page.
AvePoint, Inc. (AVPT) insider filing shows Executive Chairman and Director reported open‑market sales of common stock on two dates. On 11/03/2025, 41,679 shares were sold at $13.96 per share. On 11/04/2025, 18,321 shares were sold at $13.80 per share.
The transactions were made under a Rule 10b5-1 trading plan adopted on June 22, 2025. Following these sales, the reporting person beneficially owned 15,040,668 shares indirectly, held by various trusts and LLCs for which he is affiliated or acts as trustee.
AvePoint (AVPT) reported an insider transaction by its Director and Chief Legal Officer. On October 24, 2025, the reporting person sold 1,848 shares of common stock at $15.03 per share under a Rule 10b5-1 plan adopted on December 18, 2024. Following the sale, the reporting person beneficially owned 631,893 shares, held directly. Beneficial ownership includes non‑RSU shares and RSUs subject to previously disclosed vesting schedules.
AvePoint (AVPT) disclosed an insider transaction by its Chief Executive Officer and director on 10/17/2025. The reporting person exercised stock options and acquired common shares in three transactions: 299,435, 158,634, and 37,974 shares, at exercise prices of $1.34, $1.59, and $3.91, respectively. After these exercises, the reporting person beneficially owned 2,153,502 shares, held directly.
The holdings reflect common stock and restricted stock units granted under AvePoint’s equity incentive plans, as noted in the footnotes.
AvePoint (AVPT) filed an amended Form 4 reporting that its Chief Executive Officer and Director exercised multiple stock option tranches on 10/13/2025 under the 2016 Equity Incentive Plan. The amendment adds these specific tranches to the prior filing.
The transactions (code M) cover options for 569,707 shares at an exercise price of $1.34, 362,850 shares at $1.59, and 1,716,047 shares at $3.91, each into common stock. Following these entries, the reported remaining derivative securities beneficially owned declined sequentially to 3,000,104, with ownership shown as Direct. Table I reflects no separate non-derivative share transactions in this excerpt.
AvePoint, Inc. (AVPT) CEO and Director reported an insider transaction. On 10/15/2025, the reporting person transferred 1,542,779 shares of common stock from direct ownership to River Valley Ltd. in connection with a loan repayment totaling $22,542,001, reported as a change in the form of ownership (Code J). The transaction carried a reported price of $14.61 per share.
Following the transaction, direct beneficial ownership was 1,657,459 shares. Indirect beneficial ownership was 15,384,632 shares, held by trusts and LLCs as noted. Footnotes state indirect holdings include shares at entities affiliated with or overseen by the reporting person.
AvePoint (AVPT) reported insider transactions by its Chief Executive Officer and Director on 10/13/2025. The reporting person exercised stock options (transaction code M) and acquired common stock (coded A) at an exercise price of $14.61 per share in three tranches of 569,707, 362,850, and 1,716,047 shares. Following these transactions, the reporting person directly beneficially owned 3,200,238 shares. The filing notes these holdings include vested and unvested RSUs granted under the company’s equity plans.
AvePoint, Inc. (AVPT) director and Executive Chairman Gong Xunkai reported two scheduled stock sales under a Rule 10b5-1 trading plan adopted on 06/22/2025. On 10/06/2025 he sold 55,833 shares at $15.31, and on 10/07/2025 he sold 4,167 shares at $15.08. After these transactions he is reported to beneficially own 15,100,668 shares held indirectly through several trusts and LLCs for which he serves as trustee or is an affiliate.
The filing notes the sales were effected pursuant to the pre-established trading plan and disclaims direct beneficial ownership of trust and LLC holdings except to the extent of pecuniary interest. The form was signed by an attorney-in-fact on 10/08/2025.
AvePoint, Inc. director and Executive Chairman Xunkai Gong reported a sale of 31,950 shares of common stock on 09/29/2025 at $15.34 per share under a Rule 10b5-1 trading plan adopted on 06/22/2025. The filing shows Mr. Gong beneficially owns 15,188,718 shares following the sale, held indirectly through several trusts and LLCs (Giocoso Holdings LLC, Cadenza Holdings LLC, Vivace Holdings LLC, The Purple Harbor Trust, The Purple Cove Trust, and G Sonata Trust). The report states he disclaims beneficial ownership of trust/LLC shares except to the extent of his pecuniary interest.
The transaction was reported on Form 4 and was executed pursuant to a pre-established trading plan, indicating the sale was planned rather than opportunistic based on undisclosed material information.
AvePoint, Inc. insider sale of 35,000 common shares executed under a Rule 10b5-1 plan. The reporting person, Brian Michael Brown, who serves as Chief Legal Officer and a director, reported three sales totaling 35,000 shares on 09/23/2025 at prices between $15.49 and $15.59 per share. Following these transactions the filing shows beneficial ownership reported in the ranges of 650,474 down to 633,741 shares across the reported lines, which the filer states includes both non-RSU common stock and aggregate vested and unvested RSUs subject to previously reported vesting schedules. The filing notes the sales were made pursuant to a 10b5-1 trading plan adopted December 18, 2024.
AvePoint, Inc. (AVPT) Form 4 summary: The company’s Chief Legal Officer and director, Brian Michael Brown, reported two transactions in September 2025. On 09/19/2025 he had 1,547 shares disposed at $15.67 each, identified as withholding of shares to satisfy tax obligations upon vesting. On 09/22/2025 he reported a 30,000-share acquisition tied to the exercise of stock options (exercise price $1.3357) with a reported price of $15.75. Following these transactions, the filing shows 668,741 shares of common stock directly held and an aggregate beneficial ownership of 2,286,102 shares (including derivative securities and RSUs).
Jiang Tianyi, who serves as Chief Executive Officer and a director of AvePoint, Inc. (AVPT), reported a transaction on 09/19/2025 in which 4,706 shares of common stock were disposed of at $15.67 per share. The filing states this disposition was an exempt, non-discretionary transaction consisting of shares withheld by the company to satisfy income tax withholding obligations related to the net settlement of vested restricted stock units (RSUs). After the withholding, the reporting person beneficially owned 551,634 shares, which includes both non-RSU common stock and vested and unvested RSUs previously reported. The transaction was signed by an attorney-in-fact on 09/23/2025.
AvePoint director and Executive Chairman Gong Xunkai reported a transaction on 09/19/2025 relating to the company’s common stock and restricted stock units under the 2021 Equity Incentive Plan. The filing shows 6,500 shares were disposed of at an effective price of $15.67 in an exempt transaction where shares were withheld to satisfy tax withholding obligations on RSU vesting. After the withholding, the reporting person beneficially owned 763,702 shares (including vested and unvested RSUs). The Form 4 was signed by an attorney-in-fact on 09/23/2025.
Caci James, AvePoint (AVPT) Chief Financial Officer, reported a withholding of 2,823 shares on 09/19/2025 at a price of $15.67 per share to satisfy tax obligations related to vested restricted stock units (RSUs). The filing states this was an exempt, non‑discretionary transaction consisting of delivery/withholding of shares to pay taxes in connection with RSU vesting. Following the transaction, the reporting person beneficially owns 210,207 shares, which includes vested and unvested RSUs held under previously reported grant schedules.
AvePoint director John Chi On Ho reported the sale of 650,000 shares of common stock on 09/18/2025 at $15.21 per share. The filing shows the shares were sold to provide initial liquidity for the company's secondary listing on the Singapore Exchange; no shares were sold on Nasdaq in connection with this transaction. After the sale, the reporting person is shown as beneficially owning 3,732,679 shares indirectly through Balmoral Blue Limited, subject to a disclaimer of full beneficial ownership.
The sale was executed under Rule 144 and the company's insider trading policies. The report is limited to this non-derivative equity transaction and explains the reporting person’s indirect ownership via Balmoral Blue Limited.
AvePoint Executive Chairman and Director Gong Xunkai reported a sale of 2,068,966 common shares on 09/18/2025 at $15.21 per share conducted in connection with AvePoint's secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST). The filing states the sale facilitated initial liquidity for the SGX-ST listing, was executed in accordance with Rule 144 and applicable insider trading policies, and that no shares were sold on NASDAQ. Following the transaction the reporting person beneficially owns 15,220,668 shares, comprised of shares held by affiliated LLCs and trusts for which he is trustee, with a disclaimer limiting admission of beneficial ownership.
AvePoint director and CEO Dr. Jiang Tianyi reported a sale of 2,068,966 common shares at $15.21 per share on 09/18/2025 to facilitate initial liquidity for the company's secondary listing on the Singapore Exchange (SGX-ST). The filing states the sale complied with Rule 144 and insider trading policies and that no shares were sold on NASDAQ. After the transaction Dr. Jiang is reported to beneficially own 13,841,853 shares indirectly through trusts and LLCs, with the filing listing specific affiliated entities and trusts that hold those shares.
Caci James, Chief Financial Officer and director of AvePoint, Inc. (AVPT), reported a sale of 216,000 shares of the issuer's common stock on 09/18/2025 at a price of $15.21 per share executed on the Singapore Exchange Securities Trading Limited (SGX-ST) to facilitate initial liquidity related to the company's SGX-ST secondary listing. The filing states the transaction complied with Rule 144 and the company's insider trading policies. Following the reported sale, the reporting person beneficially owns 213,030 shares, which include non-RSU common stock and both vested and unvested restricted stock units (RSUs) granted under the 2021 Equity Incentive Plan as previously disclosed.
AvePoint insider sale of 500,000 shares to support SGX secondary listing. Brian Michael Brown, who serves as Chief Legal Officer and a Director, sold 500,000 shares of AvePoint common stock on 09/18/2025 at $15.21 per share as part of the company’s secondary listing on the Singapore Exchange to facilitate initial liquidity. The filing states no shares were sold on NASDAQ and the transaction was executed in accordance with Rule 144 and company insider trading policies. After the sale the report shows 640,288 shares beneficially owned indirectly, held by the Brian M. Brown Revocable Trust.